home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

'RNAi, MicroRNAs-2008-Boston' Meeting on RNA interference: Biochemistry to Drugs & Therapeutics

  February 01, 2008  

GeneExpression Systems, Inc., Hilton Garden Inn, 420 Totten Pond Road, Waltham, MA 02451 USA
April 7-8, 2008

 “A Unique Meeting Completely Dedicated to RNAi and its Applications”

Topics or Highlights of the Meeting:

The Biochemical Genetics of RNAi and microRNAs

RNAi Biochemistry and Mechanisms in various organisms

RNAi, MiRNAS in Stem Cells

New vectors for RNAi delivery in vivo, in vitro

microRNAs discovery and their diverse roles in biology

Computational and Disease Biology of miRNAs

Drug Target identification and Validation

High throughput genome-wide screenings

Innovative strategies to develop anti-viral, ocular and cancer therapeutics


 Key words: RNAi, microRNAs, siRNAs, piRNAs, RNAi delivery, drug target validation, genome wide screenings, shRNA libraries

Target audience:              

Executives, Directors and Scientists of R&D from biotech and pharmaceuticals.            

Graduate students, Post-docs, and Professors from Academia.              

Investors, Thought leaders and Business Development people in life sciences who need to know

 the emerging technologies.

Organized by: GeneExpression Systems, Inc.
Invited Speakers:

Organizers: Krishnarao Appasani (GeneExpression Systems, Inc.); Roberto Weinmann (Bristol Myers Squibb), Mehmet Yanik (MIT), Joanne Weidhaas (Yale).


Keynote Speaker: Dr. Craig P. Hunter (Harvard), Harvey F. Lodish (MIT), Keith McCullagh, President, Santaris Pharma, Denmark


Speakers include: Klaus Rajewsky of Harvard Medical School, Mehmet Yanik, Jianzhu Chen of MIT, Ramesh Akkina of Colorado State University,  Claes Wahlestedt of Scripps Florida, John Maraganore of Alnylam, Sven Diederichs of Mass. General Hospital, Thomas Duchaine of McGill, Don-ki Lee of Korea, Clark Chen of Dana-Farber Cancer Institute, Li Ma of Whitehead Institute, Feng Guo of UCLA, James Collins of BU, and several biotech and pharmaceutical Communities will be speaking on the biology of RNAi and their utilizations in Target validation, drug and therapeutic development.

Deadline for Abstracts: March 6, 2008

Registration Fee: Students; 399 US Dollars

Academia: 699 US Dollars

Industry: 1199 US Dollars

E-mail: Genexpsys@expressgenes.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.